Edition:
United Kingdom

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

1.70USD
14 Dec 2018
Change (% chg)

$0.06 (+3.66%)
Prev Close
$1.64
Open
$1.66
Day's High
$1.70
Day's Low
$1.60
Volume
7,324
Avg. Vol
23,032
52-wk High
$8.10
52-wk Low
$1.46

Latest Key Developments (Source: Significant Developments)

Obalon Therapeutics Q2 Loss Per Share $0.57
Thursday, 2 Aug 2018 

Obalon Therapeutics Inc ::OBALON ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.57.Q2 REVENUE $2.7 MILLION VERSUS I/B/E/S VIEW $3.3 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.51 -- THOMSON REUTERS I/B/E/S.  Full Article

Obalon Therapeutics - On July 10 Entered Into Loan Amendment With Pacific Western Bank
Friday, 13 Jul 2018 

July 13 (Reuters) - Obalon Therapeutics Inc ::OBALON THERAPEUTICS - ON JULY 10 ENTERED INTO LOAN AMENDMENT WITH PACIFIC WESTERN BANK, WHICH AMENDED LOAN, SECURITY DEAL, DATED AS OF JUNE 14, 2013.OBALON THERAPEUTICS SAYS LOAN AMENDMENT INCREASING TOTAL BORROWINGS UP TO $20.0 MILLION IN TWO TRANCHES -SEC FILING.OBALON THERAPEUTICS INC - LOAN AMENDMENT EXTENDING MATURITY DATE TO JULY 9, 2022.  Full Article

Obalon Therapeutics Announces Proposed Public Offering Of $35 Mln Shares
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - Obalon Therapeutics Inc ::OBALON THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.OBALON THERAPEUTICS INC - ‍COMMENCING AN UNDERWRITTEN PUBLIC OFFERING OF $35 MILLION OF SHARES OF ITS COMMON STOCK​.  Full Article

Obalon Therapeutics Q3 loss per share $0.55
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Obalon Therapeutics Inc :Obalon announces third quarter 2017 financial results.Q3 revenue $2.8 million versus I/B/E/S view $2.9 million.Q3 loss per share $0.55.Q3 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S.  Full Article

Obalon Therapeutics & Sono Bello announce agreement to offer novel weight loss treatment
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Obalon Therapeutics Inc :Obalon Therapeutics Inc and Sono Bello announce agreement to offer novel weight loss treatment in Sono Bello centers.Obalon Therapeutics Inc - ‍co, Sono Bello announced that they had reached an agreement to begin offering Obalon balloon system​.Obalon Therapeutics Inc - ‍Obalon balloon system will be exclusive non-invasive weight loss technology offered in Sono Bello centers​.  Full Article

Obalon Therapeutics files for mixed shelf of up to $100 mln
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Obalon Therapeutics Inc ::Files for mixed shelf of up to $100 million - SEC filing‍​.Says in addition, selling stockholder may offer and sell up to 150,000 shares of co's common stock.  Full Article